#1PST.MI— POSTE ITALIANE
€25,66Forte acquistoDip attivo🇮🇹 ITClenow 42,8W: Laterale8% dal highEARN: 2026-11-11 (61d)DATA GAP
Poste Italiane is Italy's former postal monopoly turned diversified financial-services and logistics group, and it is misleading to think of it as a mail company: letters and parcels generate a minority of profit, while the bulk of earnings comes from money. The group runs four businesses. (1) Mail, Parcels & Distribution: universal postal service plus a fast-growing parcel arm riding Italian e-commerce, distributed through roughly 12,800 post offices — by far the densest retail network in the country and the real strategic asset, since it is also the distribution channel for everything else. (2) Financial Services (BancoPosta): current accounts and postal savings products (libretti and buoni fruttiferi postali) placed on behalf of Cassa Depositi e Prestiti for a fee, plus retail deposits that are largely remunerated by the Treasury and invested in a large portfolio of Italian government bonds — meaning that a big slice of group profit is effectively a carry trade on BTP yields, with fee income rather than credit risk on the lending side. (3) Insurance Services (Poste Vita), one of Italy's largest life insurers, dominated by Class I separately-managed (gestioni separate) policies sold through the same branch network, plus a smaller P&C arm. (4) Payments & Mobile (PostePay), the leading Italian prepaid-card franchise plus a mobile virtual operator (PosteMobile) and, more recently, retail energy supply. Ownership is the other defining feature: the State controls the company through the Ministry of Economy and Finance and Cassa Depositi e Prestiti, which together hold roughly two thirds of the capital. That makes Poste a hybrid — a cash-generative, high-payout, low-beta financial utility with a captive retail base, but one whose capital-allocation decisions can be driven by national industrial policy as much as by shareholder returns.
P/E: 13,8 (fwd: 13,0)Rev Growth: +3%Margini: 16,6%ROE: 18,2%
Scenari di rimbalzoDiptestato storicamenteEntry €25,66
Best SharpeConsigliato
Obiettivo€28,55
Tempo max240g
Tasso successo85%
Rendimento medio+6,2%
Max CAGRAggressivo
Obiettivo€30,10
Tempo max120g
Tasso successo73%
Rendimento medio+8,5%
Min MaxDDConservativo
Obiettivo€28,10
Tempo max120g
Tasso successo75%
Rendimento medio+4,7%
Hold-to-target — nessuno stop loss (nei backtest lo stop riduce i profitti su tutte le categorie). Tasso di successo e rendimento medio sono medie storiche di categoria, non valori del singolo titolo.
The dominant theme is not the operating business — which is running well — but the takeover of TIM (Telecom Italia). Poste, already TIM's largest shareholder with a stake of roughly 28% built up from the Vivendi block, launched a public exchange offer for the rest of the telco: €1.67 in cash plus 0.218 newly issued Poste shares per TIM share. The consideration was sweetened in early September and the deal is now valued at about €13.4 billion, up from the roughly €10.8 billion originally announced, reflecting the run-up in both share prices. Crucially, Poste waived the 66.67% minimum acceptance threshold, keeping the bid alive even without overwhelming take-up: the initial acceptance window closed on 11 September 2026, with a reopening from 21 to 25 September. The market's read has been cautious — the stock fell 2.77% to €25.66 on 9 September on the improved cash terms plus a broader selloff — because a fully diversified financial group is using its own paper and cash to consolidate a capital-intensive, structurally challenged telecom operator, with the added complication of control over TIM Brasil coming into play. Operationally, meanwhile, H1 2026 was a record: revenues up about 6% to €6.8 billion, adjusted EBIT up 7% to €1.8 billion, net profit up 4% to €1.2 billion, and cash generation of nearly €900 million, with parcels, insurance and PostePay all contributing. Management confirmed 2026 guidance and raised the full-year operating-profit target to about €3.4 billion, with revenues around €13.5 billion, net profit excluding the TIM stake of about €2.3 billion, and the investment-portfolio return target lifted to €2.8 billion on a friendlier rate environment. The dividend policy was reaffirmed at a payout above 70% of net profit excluding TIM, with TIM dividends passed through cash-for-cash (roughly €100 million expected in 2027) and an accretive policy from 2027; a full multi-year strategic plan incorporating TIM is due before year-end 2026. Sell-side sentiment is mixed rather than hostile: consensus targets sit modestly above the current price, but JP Morgan moved to Neutral arguing that the scope for further positive earnings surprises is now limited after a long run of beats.
thumb_upA favore
- check_circleRecord H1 2026 with an upgraded outlook: revenues +6% to €6.8bn, adjusted EBIT +7% to €1.8bn (outpacing revenue), net profit +4% to €1.2bn and cash generation of nearly €900m; management confirmed 2026 guidance and RAISED the full-year operating-profit target to about €3.4bn on revenues of ~€13.5bn.
- check_circleShareholder remuneration is explicit and ring-fenced from the deal: payout above 70% of net profit excluding the TIM stake (net profit ex-TIM guided at ~€2.3bn for 2026), with TIM dividends passed through cash-for-cash (~€100m expected in 2027) and an accretive dividend policy from 2027 — the standalone 2026 policy was confirmed unchanged despite the takeover.
- check_circleThe investment portfolio is working: the 2026 total portfolio return target was lifted to €2.8bn on a more favourable rate environment. BancoPosta's large Italian government-bond book plus the Treasury-remunerated deposit base turns higher yields into recurring, low-credit-risk profit.
- check_circleStructurally advantaged distribution: roughly 12,800 post offices — the densest retail network in Italy — sell parcels, insurance, payments, mobile and energy to a captive base. Growth in H1 came simultaneously from parcels, insurance and PostePay, which is what makes the earnings mix less mail-dependent than the name suggests.
- check_circleThe TIM transaction, if executed at the current terms, consolidates a business Poste already influences as the largest shareholder (~28%) and comes with a defined 2026-2029 industrial path and a TIM remuneration policy of its own (a buyback of up to €400m and roughly €0.5bn of dividends payable in 2027, i.e. 70% of available cash flow).
thumb_downContro
- cancelThe waiver of the 66.67% acceptance threshold is the key red flag: Poste kept the bid alive without the take-up it originally required, so it can end up controlling — and having to consolidate — a capital-intensive telco while carrying a large minority it did not want, with none of the clean-squeeze-out flexibility a high acceptance would have given.
- cancelThe consideration is partly Poste's own paper (€1.67 cash plus 0.218 new Poste shares per TIM share), so every point of acceptance dilutes existing holders, and the total value has already inflated from ~€10.8bn to ~€13.4bn as both share prices rose. TIM management itself has said synergies with Poste will have NO impact in 2026 — the cost is immediate, the benefit is not.
- cancelOwnership and incentives: the State controls Poste through the MEF and Cassa Depositi e Prestiti (roughly two thirds of capital combined), and the TIM deal is widely read as state-directed industrial policy. Minority shareholders bear the execution risk of a national-champion construction they did not underwrite.
- cancelValuation and expectations have caught up: after a strong run the consensus target sits only modestly above the price, and JP Morgan cut to Neutral explicitly because the scope for further positive earnings surprises now looks limited. The stock fell 2.77% to €25.66 on 9 September on the improved cash terms plus the broader selloff.
- cancelThe earnings engine is rate- and sovereign-sensitive: the raised portfolio-return target is a direct function of the rate environment. ECB easing compresses reinvestment yields, and a widening BTP spread hits both the mark-to-market of the bond book and Poste Vita's separately-managed accounts. The legacy mail business also keeps declining structurally while parcels face Amazon's in-house logistics.
Bear case · Buying TIM turns Poste into an integrated national champion whose synergies and pass-through TIM dividends make the deal accretive for Poste shareholders from 2027. → TIM's own management has stated that synergies with Poste will have no impact in 2026, while the dilution from the 0.218 new Poste shares per TIM share and the €1.67 cash component is immediate. Poste waived the 66.67% acceptance threshold, so the realistic outcome may be control with a large unwanted minority — consolidating a capital-intensive telco with a long history of value destruction, plus TIM Brasil control complications, without the clean structure needed to extract cash. The pass-through dividend is quantified at only ~€100m in 2027 against a purchase price that has already inflated to ~€13.4bn.
Bear case · The core business's record H1 and the raised €3.4bn operating-profit target justify paying up for a low-beta compounder with a >70% payout. → A material share of that profit is a carry trade: the portfolio-return target was raised BECAUSE the rate environment improved, so it falls back when the ECB eases or the BTP spread widens — neither is under management's control. JP Morgan downgraded to Neutral precisely on the view that the run of positive surprises is exhausted, and the shares already trade near consensus targets. If the rate tailwind fades while TIM absorbs cash and management attention, the payout that underpins the valuation is the line item under pressure.
eventTrimestrale 2026-11-11 (tra 61g) · 9M/Q3 2026 results expected in early-to-mid November 2026 (indicative date — check the company's financial calendar). Focus on: (1) the outcome and accounting treatment of the TIM offer after the initial window closed on 11 September and the 21-25 September reopening — final acceptance level, resulting stake, dilution from newly issued shares and whether TIM is consolidated; (2) delivery against the raised FY2026 targets (adjusted EBIT ~€3.4bn, revenues ~€13.5bn, net profit ex-TIM ~€2.3bn); (3) the investment-portfolio return versus the €2.8bn target and its sensitivity to ECB policy and the BTP spread; (4) confirmation that the >70% payout on net profit ex-TIM survives the deal; (5) the multi-year strategic plan incorporating TIM, due before year-end 2026.candlestick_chartTradingView #2MAR— Marriott International
$329,07AcquistoPullback su trend🇺🇸 USClenow 44,2W: Markdown18% dal highEARN: 2026-11-03 (62d)DATA GAP
Marriott International is the world's largest hotel company by room count, operating an asset-light franchising and management model: it owns very few buildings and instead licenses ~30 brands (Marriott, Sheraton, Westin, Ritz-Carlton, St. Regis, Courtyard, Residence Inn, Autograph Collection, Moxy) to third-party owners and developers, collecting a percentage of room revenue as base and franchise fees plus incentive fees tied to hotel profitability. Think of it as a toll booth on hotel stays rather than a landlord: the owner carries the real estate, the construction cost and the operating leverage, while Marriott supplies the brand, the reservation system, the revenue-management technology and the distribution. The economic engine behind this is Bonvoy, the loyalty programme with well over 200 million members, which drives direct bookings (cheaper than online travel agencies for owners) and generates high-margin co-brand credit-card fees from bank partners. Because fee income scales with the room base rather than with capital deployed, the model throws off large free cash flow that management routes almost entirely into buybacks and dividends. The two variables that matter are RevPAR (revenue per available room — occupancy times average daily rate, i.e. how well existing hotels are doing) and net rooms growth (how fast the system is expanding), and the pipeline of signed-but-unopened rooms gives multi-year visibility on the second.
P/E: 34,3 (fwd: 25,0)Rev Growth: +11%Margini: 35,0%PEG: 3,42
Scenari di rimbalzoFallentestato storicamenteEntry $329,07
Best SharpeConsigliato
Obiettivo$474,38
Tempo max180g
Tasso successo80%
Rendimento medio+18,9%
Max CAGRAggressivo
Obiettivo$474,38
Tempo max180g
Tasso successo80%
Rendimento medio+18,9%
Min MaxDDConservativo
Obiettivo$438,05
Tempo max150g
Tasso successo79%
Rendimento medio+16,4%
Hold-to-target — nessuno stop loss (nei backtest lo stop riduce i profitti su tutte le categorie). Tasso di successo e rendimento medio sono medie storiche di categoria, non valori del singolo titolo.
Marriott is entering the back half of 2026 with the fee engine running better than the top line suggests. Q2 2026 delivered global RevPAR up 3.4%, with US & Canada up 5% — the strongest quarterly print in 13 quarters — while adjusted EBITDA rose 13% to $1.59B and adjusted EPS jumped 20% to $3.19, showing how operating leverage in an asset-light model amplifies modest RevPAR gains. Management raised full-year systemwide RevPAR guidance to 3%–3.5% and full-year EPS growth to 16%–18%. The offsetting story is international: RevPAR abroad fell 0.5%, with EMEA down more than 5% on a 43% collapse in Middle East bookings, and construction delays in the region pushed full-year net rooms growth to the low end of the 4.5%–5% range. The development pipeline remains a record ~610,000 rooms, which underwrites the multi-year unit growth thesis. Capital return stays aggressive — 3.0M shares repurchased for $1.1B in Q2, $2.2B year-to-date through late July — funded partly with new debt: roughly $1.24B raised in August 2026 across 4.875% notes due 2029 and 5.650% notes due 2036, against total debt of $16.9B versus $0.5B of cash. The market's hesitation is about price, not operations: MAR trades near 27.5x forward earnings against ~20.4x for the hotel sub-industry and ~20.6x for the S&P 500, and the 37-analyst consensus sits at neutral with a median target around $282.
thumb_upA favore
- check_circleQ2 2026 showed the asset-light operating leverage working: RevPAR +3.4% globally translated into +13% adjusted EBITDA ($1.59B) and +20% adjusted EPS ($3.19). A low-single-digit revenue variable driving mid-teens/20% bottom-line growth is the whole point of a fee-based model, and it is currently delivering.
- check_circleUS & Canada RevPAR +5% was the best quarterly figure in 13 quarters — the domestic core, which is the largest fee pool, is reaccelerating rather than rolling over, and it is what allowed management to raise full-year systemwide RevPAR guidance to 3%-3.5% and FY EPS growth to 16%-18%.
- check_circleRecord development pipeline of roughly 610,000 rooms plus ~17,900 net rooms added in Q2 (+4.5% YoY system growth) gives multi-year visibility on unit expansion that is largely independent of the cycle: owners fund the construction, Marriott collects the fees on rooms that are already contractually signed.
- check_circleCapital return is aggressive and consistent: 3.0M shares bought back for $1.1B in Q2, $2.2B year-to-date through late July. On an asset-light balance sheet the free cash flow conversion is high, so buybacks compound EPS on top of the fee growth.
- check_circleBonvoy remains a structural moat: 200M+ members drive direct bookings that cost owners less than OTA channels, which is the argument that keeps owners signing, and the co-brand credit-card economics deliver high-margin fee income that is far less cyclical than room revenue itself.
thumb_downContro
- cancelThe international leg is broken, not just soft: RevPAR abroad fell 0.5%, EMEA dropped more than 5%, and Middle East bookings collapsed 43% year-over-year. That same disruption pushed full-year net rooms growth down to the low end of the 4.5%-5% range on construction delays — so the geopolitical hit is now touching the unit-growth story, not only the RevPAR line.
- cancelValuation leaves no room for error: ~27.5x forward earnings versus ~20.4x for the hotel sub-industry, ~20.6x for the S&P 500 and ~16.5x for consumer discretionary. A 35% premium to the peer group on 3% RevPAR growth means the multiple is doing most of the work, and any guidance trim re-rates the stock faster than the fundamentals deteriorate.
- cancelLeverage is being used to fund the buyback: $16.9B total debt against $0.5B cash, with a further ~$1.24B raised in August 2026 at 4.875% (2029) and 5.650% (2036). Borrowing at 5.65% to repurchase stock at 27.5x forward earnings (a ~3.6% earnings yield) is not obviously accretive, and it consumes the flexibility that would matter in a travel downturn.
- cancelIncentive fees are the most cyclical part of the fee stack — they are tied to hotel-level profitability, so they compress faster than base fees when RevPAR stalls. Combined with tighter owner financing, a slowdown would hit both the fee mix and the pace of new signings at the same time.
- cancelAnalyst consensus is neutral, not bullish: the 37-analyst median target sits around $282 (range $205-$332), which implies the sell side sees the operational strength as already reflected in the price.
Bear case · The record ~610,000-room pipeline converts into 4.5%-5% net rooms growth annually, making unit expansion a reliable, cycle-independent driver of fee income. → Management has already cut FY26 net rooms growth to the LOW END of that range because of Middle East construction delays — the pipeline is a signed intention, not a contracted delivery schedule, and it depends on third-party owners securing financing. With owner financing tightening and regional disruption broadening, signed rooms can slip by quarters or years without ever showing up as a cancellation, so the pipeline number overstates near-term visibility.
Bear case · The 27.5x forward multiple is justified because the asset-light model converts low-single-digit RevPAR into 16%-18% EPS growth durably. → A meaningful slice of that EPS growth is bought, not earned: $2.2B of buybacks year-to-date funded in part by $1.24B of new debt at 4.875%-5.65% against $16.9B of existing debt. Strip out share-count reduction and the underlying fee growth is far closer to the 3%-3.5% RevPAR line. If RevPAR flattens, incentive fees compress first and the buyback becomes harder to sustain at the same pace — leaving a ~35% peer premium supported by mid-single-digit organic growth.
Bear case · The Middle East weakness is an isolated, transitory regional shock that will not spread to the rest of the international portfolio. → The 43% Middle East booking decline was already enough to drag all of EMEA down more than 5% and flip total international RevPAR negative (-0.5%), and it is simultaneously delaying construction there. The channel is geopolitical rather than economic, which means there is no mean-reversion timetable to underwrite. With US & Canada carrying the entire consolidated result, a domestic travel slowdown on top of a still-impaired international book would remove the offset entirely.
eventTrimestrale 2026-11-03 (tra 62g) · Q3 2026 print expected in early November (Q2 was reported 3 Aug 2026 — date not yet formally confirmed). Focus on: whether US & Canada RevPAR holds the +5% reacceleration, whether Middle East/EMEA bookings stabilise after the -43% collapse, confirmation or a further trim of the 4.5%-5% net rooms growth range, and whether the raised FY guidance (systemwide RevPAR +3%-3.5%, EPS growth +16%-18%) is reiterated. Also watch buyback pace versus the August debt raise.candlestick_chartTradingView #3LLY— Eli Lilly and Company
$1123,00Forte acquistoFallen angel🇺🇸 USClenow 23,7W: Markdown12% dal highEARN: 2026-10-29 (48d)
Eli Lilly and Company (LLY) is a US pharmaceutical group founded in 1876 and headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and sells prescription medicines worldwide, organised around a handful of therapeutic franchises: cardiometabolic health (diabetes and obesity — Mounjaro/Zepbound tirzepatide, Foundayo/orforglipron, Trulicity, Humalog and the rest of the insulin portfolio), oncology (Verzenio, Jaypirca, Retevmo), immunology (Taltz, Omvoh, Ebglyss) and neuroscience (Kisunla for Alzheimer's, Emgality). Its economics are those of a branded-pharma manufacturer: very high gross margin (mid-80s percent of revenue), heavy R&D spend, and revenue concentrated in a small number of patent-protected molecules whose exclusivity eventually expires. Lilly is one of the largest pharmaceutical companies in the world by market capitalisation and is the single biggest player in the GLP-1 incretin market for type 2 diabetes and obesity.
P/E: 37,7 (fwd: 23,8)Rev Growth: +48%Margini: 33,5%ROE: 102,3%PEG: 1,48
Scenari di rimbalzoCorrezionetestato storicamenteEntry $1123,00
Best SharpeConsigliato
Obiettivo$1296,07
Tempo max150g
Tasso successo77%
Rendimento medio+7,9%
Max CAGRAggressivo
Obiettivo$1437,68
Tempo max150g
Tasso successo82%
Rendimento medio+11,3%
Min MaxDDConservativo
Obiettivo$1311,81
Tempo max120g
Tasso successo72%
Rendimento medio+6,3%
Hold-to-target — nessuno stop loss (nei backtest lo stop riduce i profitti su tutte le categorie). Tasso di successo e rendimento medio sono medie storiche di categoria, non valori del singolo titolo.
Lilly is in the steepest growth phase in its history, driven almost entirely by the incretin franchise. Q2 2026 revenue was $23.0 billion, up 48% year on year, with volume up 60% and realised prices down 13% — the exact shape of the current story: enormous volume growth paid for with price concessions. EPS came in at $8.38 versus roughly $6.01 expected, gross margin rose to 86.3% of revenue on better production costs and mix, and management raised full-year 2026 guidance to $85-87 billion from $82-85 billion. The strategic event of 2026 is the shift from injectables to pills. Foundayo (orforglipron), the first oral GLP-1 that can be taken any time of day without food or water restrictions, was approved by the FDA in April 2026 under the national priority voucher programme and booked $98 million of sales in its first partial quarter; Lilly has since filed orforglipron for type 2 diabetes in the US, EU and Japan, and launched Foundayo commercially in the UK in August 2026, its first European market. Sell-side 2026 estimates for the pill span roughly $1.5-2.8 billion with peak-sales projections that run above $40 billion — a wide range that tells you how little is actually settled. The competitive and political backdrop tightened at the same time: Novo Nordisk got its oral Wegovy to market about three months ahead of Foundayo and is running roughly 50,000 weekly prescriptions, and under the most-favoured-nation deals struck with the Trump administration both companies now sell through the TrumpRx channel, with cash prices starting near $149/month for the lowest dose and a $50 Medicare copay, while Medicare begins covering obesity drugs for some patients from mid-2026. That expands the addressable market and compresses price per patient simultaneously. The stock carries a premium large-cap pharma multiple and the sell-side consensus is Buy/Strong Buy with 12-month targets clustered around $1,250-1,320 and a dispersion from roughly $850 to $1,500.
thumb_upA favore
- check_circleGrowth is exceptional and still accelerating: Q2 2026 revenue of $23.0 billion, +48% year on year on +60% volume, with EPS of $8.38 versus roughly $6.01 expected (a ~39% beat) and full-year 2026 guidance raised to $85-87 billion from $82-85 billion.
- check_circleBest-in-class manufacturing economics for a company growing this fast: gross margin reached 86.3% of revenue in Q2 2026, up 1.3 percentage points year on year on lower production cost and favourable mix — margin expanded even while realised prices fell 13%, which means the volume ramp is paying for itself rather than being bought.
- check_circleFoundayo (orforglipron) opens the oral GLP-1 market: FDA-approved in April 2026 under the national priority voucher programme, the only GLP-1 pill for weight loss with no food or water timing restrictions, $98 million of sales in its first partial quarter, and now filed for type 2 diabetes in the US, EU and Japan. A pill removes the cold-chain, injection-device and capacity constraints that cap injectable GLP-1 volumes.
- check_circleInternational expansion is already under way rather than promised: Foundayo launched commercially in the UK in August 2026, the first European market, with additional filings pending — giving the franchise a second growth vector beyond the US.
- check_circleMedicare coverage of obesity drugs starts for some patients in mid-2026 under the MFN deals, with a $50 monthly copay for approved uses. Structurally this converts a large cash-pay-only population into a reimbursed one, which historically is what turns a specialty drug into a mass-market one.
thumb_downContro
- cancelPrice is being traded for volume, deliberately and on a large scale: realised prices fell 13% year on year in Q2 2026, and the MFN/TrumpRx agreements lock in cash prices from about $149/month for the lowest dose. Revenue per patient is structurally lower than the injectable era, so growth depends on volume continuing to compound faster than price erodes.
- cancelLilly lost the first-mover slot in oral GLP-1s: Novo Nordisk's oral Wegovy was approved roughly three months earlier and is already running around 50,000 weekly prescriptions, and early commentary suggests Foundayo's launch is lagging it. In a category where formulary position and prescriber habit are sticky, arriving second matters.
- cancelRevenue concentration is extreme. The incretin franchise (tirzepatide plus orforglipron) drives essentially all of the incremental growth, so a safety signal, a manufacturing problem, a reimbursement decision or a competitor readout in that single class hits a disproportionate share of the P&L — there is no second franchise of comparable size to absorb the shock.
- cancelThe valuation embeds a long runway of the current growth rate. Sell-side 2026 estimates for Foundayo alone range from roughly $1.5 billion to $2.8 billion and price targets span $850 to $1,500 — a dispersion that shows the market has no consensus on the terminal size of the pill opportunity, which is precisely the variable the multiple rests on.
Bear case · Volume growth in the incretin franchise will keep outrunning price erosion, so the 48% revenue growth rate persists long enough to justify a premium pharma multiple. → Realised prices already fell 13% year on year in Q2 2026, and the MFN/TrumpRx deals plus the $50 Medicare copay institutionalise that lower price point rather than making it a promotional phase. Volume compounding at 60% cannot continue indefinitely once the treatment-naive pool is penetrated; when the volume curve flattens while the price concessions remain permanent, revenue growth decelerates much faster than the headline rate implies. Novo's CEO has publicly flagged pricing headwinds in an 'increasingly competitive market' — both sides of the duopoly are now discounting into each other.
Bear case · Foundayo becomes the dominant oral GLP-1 and scales toward the $40 billion-plus peak-sales figures being floated, making the pill the next leg of the story. → Foundayo booked $98 million in its first partial quarter and is reported to be lagging Novo's oral Wegovy, which launched about three months earlier across 70,000-plus pharmacies and is running roughly 50,000 weekly prescriptions. The $40 billion peak figure is an analyst projection, not an observed trajectory, and the 2026 estimate range of $1.5-2.8 billion is nearly a 2x spread — meaning the sell-side itself cannot narrow the launch curve. If Foundayo settles as the number-two oral rather than the category leader, a large part of the growth already in the price does not arrive.
Bear case · Political pricing pressure is now resolved: the MFN deals with the administration priced the risk and removed the overhang. → The deals set a precedent rather than a ceiling. Once the government has negotiated GLP-1 prices down once and is reimbursing them through Medicare, the class becomes the single largest line item to target in any future round of drug-pricing action, and IRA negotiation exposure grows as these molecules age. A company whose growth is concentrated in the one drug class with the highest political salience carries a recurring, not a retired, policy risk.
eventTrimestrale 2026-10-29 (tra 48g) · Q3 2026 results expected in late October 2026 (Lilly's usual end-October slot; Q2 was reported 5 August 2026). What matters: (1) the Foundayo/orforglipron ramp — whether the quarter shows a steep sequential step up from the $98 million first partial quarter and how scripts track against Novo's oral Wegovy; (2) realised price, after the 13% year-on-year decline in Q2, and whether gross margin holds near 86% as the MFN/TrumpRx and $50 Medicare copay pricing flows through a full quarter; (3) any further raise to the $85-87 billion full-year 2026 revenue guidance; (4) early evidence on Medicare obesity coverage volumes now that reimbursement started mid-2026; (5) regulatory timing on the orforglipron type 2 diabetes filings in the US, EU and Japan, and further ex-US launches after the UK.candlestick_chartTradingView Forte acquistoSwing momentum—Clenow 5,9W: Struttura rottaEARN: 2026-09-02 (1d)DATA GAP
Broadcom is a US infrastructure technology group built by serial acquisition, split into two engines. The larger one, Semiconductor Solutions, designs chips that move and process data rather than run consumer devices: custom AI accelerators (XPUs) co-designed with a handful of hyperscalers, Tomahawk and Jericho Ethernet switching silicon that wires data-center racks together, optical DSPs and retimers, plus long-tail franchises in broadband, storage connectivity and the RF front-end content Broadcom sells into Apple iPhones. The smaller one, Infrastructure Software, is the VMware, CA and Symantec estate: mission-critical enterprise software sold on multi-year subscriptions, repriced upward after acquisition. The business model is deliberate and repeatable — buy a company with a defensible niche, cut costs hard, raise prices on customers who cannot easily switch, and convert the result into free cash flow that funds dividends, buybacks and the next deal. That mix of near-monopoly positions in unglamorous silicon and sticky software licences is why Broadcom runs structurally higher margins than most semiconductor peers. It is fabless (manufacturing is outsourced, mostly to TSMC) and has been led for two decades by CEO Hock Tan.
P/E: 61,6 (fwd: 18,9)Rev Growth: +48%Margini: 38,8%ROE: 37,3%
Broadcom is a semiconductor and infrastructure-software group: custom AI accelerators and Ethernet networking silicon for hyperscalers on the chip side, mainframe, security and virtualization software after the VMware acquisition on the other. The last reported quarter showed revenue +48% year over year with AI semiconductor revenue +143%, net margins 39% and ROE 37%. The stock sits -23.3% below its 52-week high of $480.81 while forward P/E has compressed to 18.9x against 61.6x trailing, with PEG 0.42, so the multiple already embeds a large earnings ramp. Wyckoff reads Markdown with moderate strength: the swing structure is still broken (lower highs and lower lows) with no confirmed Higher Low, so this is a deep-drawdown setup awaiting confirmation, not a completed accumulation.
thumb_upA favore
- check_circleDeepest drawdown in the scan (-23.3%): the -20% bucket is where Wyckoff adds the most, +3.9% versus buy-immediately in our 49-stock backtest
- check_circleFundamentals intact and accelerating: revenue +48% y/y, net margins 39%, ROE 37% — the drawdown is a de-rating, not deterioration
- check_circleForward P/E 18.9x against 61.6x trailing with PEG 0.42: the multiple already discounts a large earnings ramp
- check_circleOnly fallen angel in the scan that passes the defensive filter: current ratio 2.24, D/E 74%
- check_circleAI semiconductor revenue reported +143% y/y in the latest quarter, with Q3 consensus at $29.43B revenue
thumb_downContro
- cancelQ3 earnings land on 2026-09-02, one day after entry, with options pricing an ~8% move: the entry is exposed to a binary print
- cancelWyckoff phase is Markdown, not Accumulation — no Higher Low confirmed, bearish continuation is still open
- cancelClenow 5.9 means momentum is fully broken: the -23% has no trend support underneath it yet
Bear case · The -23% drawdown is a de-rating of intact fundamentals, not the start of an AI-capex downcycle → Clenow at 5.9 and a Markdown Wyckoff phase say the tape does not agree yet; a Q3 guide below the $29.43B consensus would confirm the market rather than the thesis
Bear case · US export controls stay on case-by-case review for AI accelerators → A reversion to presumption-of-denial, or the addition of Broadcom networking silicon to the restricted list, would hit guidance directly; roughly 18% of 2024 revenue came from Greater China
Bear case · VMware repricing keeps converting into software margin → CISPE filed an EU competition complaint in March 2026 over price increases and bundling; regulatory remedies would cap the software leg of the story
loginEntry $368,79eventTrimestrale 2026-09-02 (tra 1g) · $2.55 GAAP EPS on $29.43B revenue (Q3 FY2026)candlestick_chartTradingView #5GOOGL— Alphabet Inc.
$332,60Forte acquistoPullback su trend—Clenow 37,2W: Distribuzione17% dal highEARN: 2026-10-27 (56d)
Alphabet Inc. (headquartered in Mountain View, California) is Google's holding company and one of the world's leaders in digital advertising, online search and cloud computing. The business is organised into three segments: Google Services (Search, YouTube, the advertising network, plus subscriptions/platforms/devices — Android, Pixel, Play Store), Google Cloud (Google Cloud Platform and Workspace) and Other Bets (Waymo autonomous driving, Verily, Isomorphic Labs and other early-stage ventures). Advertising revenue (Search + YouTube + Network) accounts for roughly 75-80% of the total, which makes Alphabet structurally dependent on the digital-ad cycle and on corporate marketing budgets. On the AI side the company owns DeepMind, the Gemini model family and its own custom TPU silicon: this vertical integration gives it a cost and scale advantage in compute infrastructure that most rivals — who buy merchant GPUs — do not have. The competitive moat rests on Search's dominant market share (roughly 90% of global queries), the YouTube and Android ecosystems, and a global distribution network. Structural risks: (1) antitrust pressure (the DOJ Search-monopoly case and its remedies, plus parallel ad-tech proceedings); (2) disruption of Search by chatbots and AI answer engines that threaten both query volume and per-query ad economics; (3) dependence on cyclical advertising revenue; (4) a rapidly rising capex burden for AI infrastructure, which converts a historically asset-light business into a capital-intensive one and weighs on free cash flow and depreciation.
P/E: 16,6 (fwd: 22,4)Rev Growth: +24%Margini: 54,8%ROE: 48,7%PEG: 1,22
Scenari di rimbalzoFallentestato storicamenteEntry $332,60
Best SharpeConsigliato
Obiettivo$471,64
Tempo max180g
Tasso successo80%
Rendimento medio+18,9%
Max CAGRAggressivo
Obiettivo$471,64
Tempo max180g
Tasso successo80%
Rendimento medio+18,9%
Min MaxDDConservativo
Obiettivo$436,88
Tempo max150g
Tasso successo79%
Rendimento medio+16,4%
Hold-to-target — nessuno stop loss (nei backtest lo stop riduce i profitti su tutte le categorie). Tasso di successo e rendimento medio sono medie storiche di categoria, non valori del singolo titolo.
Q2 2026 (reported 22 July 2026): consolidated revenue up 24% to $119.8 billion — the twelfth consecutive quarter of double-digit growth — with operating income up 30%. Google Services grew 15% to $94.5 billion (Search & other +17%, YouTube ads +13%, subscriptions/platforms/devices +15%). The headline number was Google Cloud: revenue up 82% to $24.8 billion, a sharp acceleration from the 48% posted in Q4 2025, with operating income more than tripling to $8.8 billion and operating margin expanding from 20.7% to 35.6%. Cloud backlog rose by more than $50 billion sequentially to $514 billion, giving unusual multi-year visibility for a hyperscaler. The offsetting item, and the reason the stock initially sold off on the print, was capex: full-year 2026 guidance was raised to $195-205 billion from the prior $180-190 billion. In early August Alphabet closed a $22.93 billion senior unsecured bond issue with maturities running from 2028 to 2066, financing part of that build with debt rather than pure operating cash flow. On adoption, Gemini has been reported above 750 million users, and management says serving unit costs fell about 78% through 2025 thanks to model optimisation and TPU efficiency — the key argument that inference economics improve as volume scales. On the legal front, the Search-monopoly remedies took a structural breakup off the table (no forced divestiture of Chrome or Android, behavioural remedies instead), but the DOJ has formally appealed seeking harsher conditions, so the overhang is reduced rather than removed. Market cap sits around $4.2 trillion in late August 2026, with the stock having recovered from the post-earnings capex scare; the trailing multiple (roughly 17x on reported earnings, with forward estimates dispersed across data providers) remains the cheapest of the mega-cap AI complex. Next catalyst: Q3 2026 results, expected in late October 2026.
thumb_upA favore
- check_circleGoogle Cloud is inflecting, not just growing: Q2 2026 revenue +82% YoY to $24.8B (vs +48% in Q4 2025), operating income more than tripled to $8.8B and margin jumped from 20.7% to 35.6%. Accelerating growth WITH expanding margin is the rare combination that justifies a re-rating — most AI revenue elsewhere in the complex arrives at diluted margins.
- check_circleBacklog gives visibility almost no other mega-cap has: cloud backlog rose more than $50B sequentially to $514B in Q2 2026. That is contracted, not pipeline, and it materially de-risks the 2027 revenue line against the recurring 'AI demand is a one-off spending burst' objection.
- check_circleVertical integration on silicon is a real cost moat: Alphabet designs its own TPUs and does not have to pay NVIDIA's gross margin on every unit of training and inference capacity. Management reports serving unit costs down ~78% through 2025 via model and hardware optimisation — the mechanism that turns Gemini scale (reported above 750 million users) from a cost centre into a margin story.
- check_circleThe core advertising engine has not cracked despite three years of 'AI kills Search' narrative: Q2 2026 Search & other +17%, YouTube ads +13%, Google Services +15% to $94.5B, twelfth consecutive quarter of double-digit consolidated growth. The bear thesis has now had multiple quarters to show up in the numbers and has not.
- check_circleValuation is the cheapest in the mega-cap AI cohort: ~$4.2T market cap on a trailing multiple around 17x reported earnings, against peers trading at meaningful premiums with slower cloud growth. Even allowing for dispersion in forward estimates across data providers, the relative discount to Microsoft and to the semiconductor complex is wide.
- check_circleThe worst-case legal outcome is off the table: the Search-monopoly remedies avoided a forced divestiture of Chrome or Android, settling on behavioural constraints. The tail risk that would have justified a structural discount on the whole business did not materialise.
thumb_downContro
- cancelCapex guidance was raised again — to $195-205B for FY2026 from $180-190B — and the stock sold off on the print. A historically asset-light, ~30%+ margin business is being converted into a capital-intensive one; depreciation from this build lands in the P&L over the coming years regardless of whether AI revenue keeps compounding.
- cancelThe build is now partly debt-financed: a $22.93B senior unsecured bond issue closed in early August 2026 with maturities out to 2066. Alphabet has the balance sheet to carry it, but funding infrastructure with debt rather than operating cash flow removes some of the cushion that made the capex ramp look costless.
- cancelAntitrust is reduced, not resolved: the DOJ has formally appealed the Search remedies seeking harsher conditions, and the appellate track keeps distribution economics (default-placement contracts, data-sharing obligations) as an open variable into 2027. A more aggressive appellate outcome would hit the highest-margin revenue line directly.
- cancelRoughly three quarters of revenue still comes from advertising, which is cyclical. A macro slowdown that compresses marketing budgets would hit Services at exactly the moment when $200B of annual capex commitments cannot be switched off — the operating leverage that works so well on the way up cuts both ways.
- cancelThe structural Search question remains genuinely unresolved. AI answer engines change the shape of a query session: even if Alphabet retains the user, monetisation per session in an AI Overview or Gemini answer is not established to match ten blue links with paid slots at the top. Current growth does not settle the question, it only postpones it.
Bear case · The $514B cloud backlog converts into revenue at high margin over the next several years, validating the $195-205B annual capex programme. → Backlog is concentrated in large multi-year AI commitments from a limited set of enterprise and AI-lab counterparties, many of whom are themselves funded by capital markets rather than operating cash flow. Contracted does not mean drawn: if the AI funding cycle tightens, customers renegotiate or slow-roll consumption, while Alphabet's depreciation on already-built capacity is fixed and non-cancellable. The 35.6% Cloud margin was earned at full utilisation — the same asset base at 70% utilisation looks very different.
Bear case · Search advertising economics survive the AI transition intact, as evidenced by Search & other still growing 17% YoY. → The transition is being managed by Alphabet's own product decisions on how much AI-generated answer to place above the ad load, so current growth partly reflects a deliberate pacing choice rather than proof that the end-state monetises equally. Users who resolve intent inside a Gemini answer never reach a sponsored link. The revenue line would show erosion late, not early, because the highest-commercial-intent queries are the last to migrate — meaning strong prints today are weak evidence about the terminal state.
Bear case · The antitrust risk is largely priced out now that a breakup has been ruled out and only behavioural remedies apply. → The DOJ has appealed seeking harsher conditions, so the ceiling on the remedy has not been fixed. Behavioural remedies that constrain exclusive default-distribution contracts attack the mechanism that delivers Search's query volume at near-zero marginal acquisition cost; mandated data-sharing lowers a rival's barrier to entry precisely when AI competitors need distribution and data most. The dollar cost of the remedy shows up gradually in traffic-acquisition economics, not as a one-time charge the market can price on a single headline.
Bear case · A trailing multiple around 17x makes Alphabet cheap relative to the mega-cap AI complex, offering downside protection. → The multiple is computed on earnings that have not yet absorbed the depreciation of the 2026-2027 capex wave, and forward P/E estimates across data providers diverge widely (roughly 16x to 26x depending on the earnings base used) — which is itself a signal that the market disagrees about normalised earnings power. If the correct denominator is post-depreciation, post-higher-interest-expense earnings, the apparent discount to peers narrows or disappears, and the 'cheap' framing stops providing a floor.
eventTrimestrale 2026-10-27 (tra 56g) · Q3 2026 results expected in late October 2026 (date not yet confirmed by the company). Focus points: (1) whether Cloud growth holds near the +82% posted in Q2 or decelerates as comparisons harden; (2) the direction of cloud backlog after the +$50B sequential build to $514B; (3) any further revision to the $195-205B FY2026 capex range and the first substantive framing of 2027 capex; (4) Search & other growth versus the +17% run-rate, as the key read on AI-driven query cannibalisation; (5) commentary on the DOJ appeal timeline and on incremental interest/depreciation drag from the August bond issue.candlestick_chartTradingView Forte acquistoFallen angel🇺🇸 USClenow 0,3W: Markdown11% dal highEARN: 2026-10-27 (56d)
3M Company is a diversified US industrial conglomerate, founded in 1902 and headquartered in St. Paul, Minnesota, built on materials science: adhesives, abrasives, coatings, films, non-woven fabrics and microreplication technologies that it recombines into tens of thousands of products. Since the April 2024 spin-off of its health care arm (Solventum), the group runs three segments: Safety & Industrial (industrial tapes and adhesives, abrasives, personal protective equipment, roofing granules, electrical markets), Transportation & Electronics (display and semiconductor materials, automotive OEM films and components, aerospace, commercial road-safety products) and Consumer (Post-it, Scotch, Command, Filtrete, Nexcare). Roughly half of revenue comes from outside the United States and the model is classic industrial-compounder: a very wide catalogue of small-ticket, high-margin consumables sold into diversified end markets, with brand and specification lock-in rather than a single product cycle. Annual sales run around $25 billion. The counterweight to that franchise is a legacy legal tail — PFAS 'forever chemicals' and the Combat Arms earplugs — that has consumed multi-billion-dollar settlements and still shapes the equity story.
P/E: 29,2 (fwd: 16,7)Rev Growth: +3%Margini: 11,9%ROE: 81,9%PEG: 3,59
Scenari di rimbalzoCorrezionetestato storicamenteEntry $162,86
Best SharpeConsigliato
Obiettivo$184,99
Tempo max150g
Tasso successo77%
Rendimento medio+7,9%
Max CAGRAggressivo
Obiettivo$203,10
Tempo max150g
Tasso successo82%
Rendimento medio+11,3%
Min MaxDDConservativo
Obiettivo$187,00
Tempo max120g
Tasso successo72%
Rendimento medio+6,3%
Hold-to-target — nessuno stop loss (nei backtest lo stop riduce i profitti su tutte le categorie). Tasso di successo e rendimento medio sono medie storiche di categoria, non valori del singolo titolo.
3M is roughly two years into CEO William Brown's operational turnaround (appointed May 2024), and the 2026 numbers show it working on the margin line. Q2 2026, reported on 21 July, beat: GAAP sales of $6.5bn (+2.4%), adjusted organic growth of 5.4%, adjusted operating margin of 24.9% (+40bps year on year) and adjusted EPS of $2.40 (+11%) against a ~$2.24 consensus; GAAP EPS jumped 33% to $1.78 as prior-year legal charges rolled off. Management raised full-year guidance for adjusted EPS to $8.80-$8.95 (from $8.50-$8.70), lifted the adjusted organic growth outlook to more than 3.5%, and is targeting 70-80bps of adjusted operating margin expansion with $5.8-$6.0bn of adjusted operating cash flow. Growth is led by Safety & Industrial ($3.09bn, organic +8%) and Transportation & Electronics ($2.07bn, +6.2%), while Consumer remains the soft spot. Capital return is steady rather than spectacular: a $0.78 quarterly dividend (reaffirmed in May 2026, a payout deliberately rebased after the Solventum spin) plus roughly $4.8bn of buybacks since the start of 2025. On litigation, the biggest overhang has visibly shrunk: the federal Combat Arms MDL — 391,283 cases — was fully dismissed on 28 April 2026 with more than $3.06bn already distributed to claimants, and the $10.3bn public-water-systems PFAS settlement plus the New Jersey resolution are being paid out on a long, pre-agreed schedule. What has not gone away is new PFAS exposure: in late May 2026 the Australian government filed a A$1.4bn claim over firefighting foam at defence bases, a reminder that the tail is international and open-ended. The stock has re-rated hard on the turnaround and now trades in the mid-to-high teens on guided 2026 EPS — no longer the deep-value, broken-industrial setup of 2023-24 — with sell-side targets clustered near $170 and a split rating book (roughly 9 buy / 8 hold / 1 sell).
thumb_upA favore
- check_circleQ2 2026 (21 July) beat and raise: adjusted EPS $2.40 (+11% YoY) versus ~$2.24 consensus, adjusted organic growth 5.4%, adjusted operating margin 24.9% (+40bps). Management lifted full-year adjusted EPS guidance to $8.80-$8.95 from $8.50-$8.70 and raised the organic growth outlook to above 3.5% — the second consecutive year in which the turnaround has delivered against its own targets rather than just promising them.
- check_circleMargin expansion is the real engine and it is still running: the company targets 70-80bps of adjusted operating margin gain for the full year plus $5.8-$6.0bn of adjusted operating cash flow. For a mature industrial with low-single-digit volume growth, self-help on cost, supply chain and factory productivity is a more controllable EPS driver than end-market demand.
- check_circleThe industrial core is accelerating, not just holding: Safety & Industrial grew organic sales more than 8% to $3.09bn and Transportation & Electronics 6.2% to $2.07bn in Q2 2026 — exposure to electrical/grid, semiconductor and display materials and aerospace, which are the parts of the industrial complex with structural demand behind them.
- check_circleThe Combat Arms overhang is effectively closed: the federal MDL covering 391,283 cases was fully dismissed on 28 April 2026, with more than $3.06bn already distributed under the $6bn settlement. The single largest binary legal risk of the last five years has moved from 'unquantified' to 'paid and dismissed'.
- check_circleConsistent capital return with a clean post-spin balance sheet: a $0.78 quarterly dividend reaffirmed in May 2026 and roughly $4.8bn of buybacks since the start of 2025, funded from operating cash flow while the settlement payment schedule runs in parallel.
thumb_downContro
- cancelPFAS is a tail risk, not a closed chapter. The $10.3bn public-water-systems settlement and the New Jersey resolution cover specific claim classes only; in late May 2026 the Australian government filed a A$1.4bn claim over firefighting foam at defence bases, and personal-injury, other sovereign and international claims remain outside any agreed cap. The liability is open-ended in a way no guidance range can capture.
- cancelThe valuation no longer pays you to wait. After the re-rating the stock trades in the mid-to-high teens on guided 2026 EPS — roughly in line with better-growing industrial peers — while underlying organic growth is only ~3.5-5%. The sell-side book is split (about 9 buy / 8 hold / 1 sell) and average targets near $170 imply modest upside; one widely-followed fair-value model puts the shares slightly above intrinsic value. The margin of safety that existed at the 2023-24 lows is gone.
- cancelEPS growth is increasingly manufactured rather than driven by the top line: adjusted EPS +11% against organic sales +5.4% is the gap between cost-out plus buybacks and actual demand. Margin expansion programmes have a finite runway, Consumer remains the weak segment, and tariff and input-cost headwinds sit directly on the same line the story depends on. Once the self-help is banked, the underlying business is a low-single-digit grower.
Bear case · The Combat Arms dismissal and the PFAS settlements mean the legal overhang is behind 3M, so cash flow can now be fully directed at dividends, buybacks and reinvestment. → Combat Arms is genuinely closed, but PFAS is not: the A$1.4bn Australian government claim filed in late May 2026 arrived AFTER the headline settlements and is precisely the category — sovereign/international claims outside the US public-water-systems class — that no existing agreement caps. The settled amounts are also paid out on a multi-year schedule that runs into the 2030s, so they compete with capital return for cash every year even absent new claims. A single adverse international precedent re-opens a liability the market has already decided to stop discounting.
Bear case · The Brown turnaround has structurally reset 3M's earnings power, justifying a mid-to-high-teens multiple on 2026 EPS of $8.80-$8.95. → Most of the improvement is margin and buyback, not volume: adjusted operating margin is up 40bps YoY with a 70-80bps full-year target, while organic growth is ~3.5-5% and Consumer is soft. Cost-out programmes decay — the second 80bps is always harder than the first — and tariffs plus input costs push the same way. If organic growth reverts toward 3M's long-run low-single-digit trend once the self-help is exhausted, the stock is a ~2%-yielding, low-single-digit grower priced like a compounder, and the multiple, not the earnings, is what corrects.
eventTrimestrale 2026-10-27 (tra 56g) · Q3 2026 results expected in late October 2026 (estimated 27 October; 3M typically reports Q3 in the last two weeks of the month — confirm on the investor-relations calendar). Watch for: (1) whether full-year adjusted EPS guidance of $8.80-$8.95 is raised again or merely reaffirmed, the key test of turnaround momentum after two consecutive beats; (2) the adjusted operating margin trajectory against the 70-80bps full-year target, and how much tariff and input-cost pressure is absorbed; (3) whether Safety & Industrial can hold ~8% organic growth and whether Consumer stops being a drag; (4) any update on PFAS reserves or the Australian A$1.4bn claim; (5) buyback pace and adjusted operating cash flow versus the $5.8-$6.0bn guide.candlestick_chartTradingView #7DAL— Delta Air Lines, Inc.
$78,24Forte acquistoPullback su trend🇺🇸 USClenow 42,7W: Markdown16% dal high
Delta Air Lines is one of the three big US legacy network carriers, alongside United and American. It flies passengers and cargo through a hub-and-spoke system anchored on Atlanta, Detroit, Minneapolis, Salt Lake City, New York (JFK/LaGuardia), Los Angeles, Seattle and Boston, plus a web of international joint ventures (Air France-KLM, Virgin Atlantic, Korean Air, LATAM, Aeromexico, WestJet). Two structural features make Delta unusual for an airline. First, it does not really sell just seats: a growing share of revenue comes from premium cabins (first, Delta One, Comfort+), from the SkyMiles loyalty programme and above all from the co-brand card deal with American Express, which pays Delta billions per year to buy miles for cardholders. That is a fee-like, higher-margin revenue stream that behaves much more like a consumer-payments annuity than like airline ticketing. Second, Delta owns the Trainer refinery in Pennsylvania, an unusual vertical-integration move that gives it a partial internal hedge against jet-fuel refining margins (the 'crack spread'). Delta also runs a large maintenance, repair and overhaul (MRO) business, TechOps, selling engine work to third-party airlines. The economics of the industry remain brutal in the abstract: airlines are capital-intensive, unionised, heavily regulated, exposed to the oil price they cannot control, and to demand that collapses in recessions, pandemics and geopolitical shocks. What separates Delta from the sector average is the mix shift toward premium and loyalty, historically the best operational reliability among US majors, and a post-COVID balance sheet that has been deleveraged back toward investment grade. It is best understood as a cyclical consumer-discretionary business with a fee-based annuity bolted onto it — not as a defensive stock.
P/E: 13,1 (fwd: 9,1)Rev Growth: +19%Margini: 5,8%ROE: 20,1%PEG: 0,79
Scenari di rimbalzoFallentestato storicamenteEntry $78,24
Best SharpeConsigliato
Obiettivo$108,62
Tempo max180g
Tasso successo80%
Rendimento medio+18,9%
Max CAGRAggressivo
Obiettivo$108,62
Tempo max180g
Tasso successo80%
Rendimento medio+18,9%
Min MaxDDConservativo
Obiettivo$101,02
Tempo max150g
Tasso successo79%
Rendimento medio+16,4%
Hold-to-target — nessuno stop loss (nei backtest lo stop riduce i profitti su tutte le categorie). Tasso di successo e rendimento medio sono medie storiche di categoria, non valori del singolo titolo.
As of September 2026, Delta is running a paradox: record operating results on one side, a severe fuel-cost shock on the other. The June quarter (reported 10 July 2026) delivered record revenue of $17.7bn, up 14% year-on-year, adjusted EPS of $1.56 and pre-tax profit of $1.4bn, beating guidance on every key metric. Management reaffirmed full-year 2026 adjusted EPS guidance of $6.50-$7.50 (roughly +20% year-on-year), free cash flow of $3-4bn, and raised the dividend 15% from the September quarter. September-quarter guidance is $2.00-$2.50 EPS on revenue up mid-teens. The headline datapoint of the quarter was structural, not cyclical: for the first time, premium-cabin ticket revenue ($6.92bn, +17%) exceeded main-cabin revenue ($6.85bn). Loyalty revenue grew 19% and American Express remittances rose 16% to $2.4bn, the seventh consecutive quarter of double-digit card-spend growth. The offsetting force is fuel. The Iran war and the disruption of Middle East supply routes have kept crude elevated and refining margins wide; Delta guided fuel at roughly $4.30 per gallon and management has quantified the 2026 headwind at close to $4bn. The response has been textbook capacity discipline: CEO Ed Bastian said the airline would 'meaningfully reduce' capacity growth, holding second-quarter capacity roughly flat year-on-year and pushing the cost through into fares — around 60% recaptured so far, with management targeting close to 100% recovery during the September quarter. The Trainer refinery is contributing a partial offset (about $300m in the June quarter). The stock has been one of the sector's better performers in 2026, up more than 20% year-to-date on some measures, though price action has been choppy and the valuation still carries the usual airline discount. The investment debate right now is whether the premium/loyalty mix shift is durable enough to justify a re-rating away from the historical airline multiple, or whether a fuel-driven margin squeeze plus any softening in high-end consumer demand drags Delta back to being priced as a pure cyclical.
thumb_upA favore
- check_circlePremium overtook main cabin for the first time: June-quarter premium ticket revenue reached $6.92bn (+17% y/y) versus $6.85bn for main cabin. This is a mix shift, not a one-off — premium buyers are less price-sensitive and their demand held up even while Delta was pushing fares higher to recover fuel costs.
- check_circleThe American Express deal is a fee-like annuity, not airline revenue: card remittances rose 16% to $2.4bn in the June quarter, the seventh straight quarter of double-digit cardholder-spend growth, with loyalty and related revenue up 19%. This stream keeps paying whether or not the specific flight is full, and it is the main argument for valuing Delta above the historical airline multiple.
- check_circleGuidance was reaffirmed while absorbing a ~$4bn fuel headwind: full-year 2026 adjusted EPS of $6.50-$7.50 (about +20% y/y) and free cash flow of $3-4bn were held, with management guiding to double-digit operating margins in the second half. Reaffirming into a cost shock is a stronger signal than beating in a benign quarter.
- check_circleCapacity discipline is being executed, not just announced: management held June-quarter capacity roughly flat year-on-year and cut planned growth in response to fuel. Historically, industry-wide capacity restraint is what lets airlines actually pass costs into fares rather than eat them.
- check_circleFare recapture is tracking: roughly 60% of the fuel increase has been passed through, with management targeting close to full recovery during the September quarter. The Trainer refinery added a further partial offset (~$300m in the June quarter), a hedge no other US major has.
- check_circleCapital returns are being raised, not defended: a 15% dividend increase starting in the September quarter, funded from a three-year cumulative free-cash-flow trajectory of over $11bn. That is a balance-sheet statement — it is not what a management team does when it fears the next four quarters.
thumb_downContro
- cancelFuel is the dominant variable and Delta does not control it. Guidance sits on roughly $4.30/gallon jet fuel driven by the Iran war and Middle East supply disruption. Delta is structurally a price-taker: the hedging book and the refinery soften the blow but cannot insulate the P&L from a sustained or worsening crude shock.
- cancelFare recapture is an assumption embedded in guidance, not a completed fact. Management has recovered ~60% and is guiding to ~100% by the September quarter. That last 40% depends on competitors staying disciplined; if any major chases share with capacity, the pass-through stalls and the fuel cost lands directly in margin.
- cancelThe premium thesis is untested in a real consumer downturn. Premium and loyalty have grown through a period of strong high-end US consumer spending. Nobody yet knows the recession elasticity of a $6.9bn premium-cabin book — the bull case implicitly assumes it behaves defensively, and that has not been observed.
- cancelCapacity cuts have a cost: holding capacity flat protects pricing but caps revenue growth and spreads fixed costs (aircraft, crews, gates, maintenance) over fewer available seat miles. Discipline is the right call under a fuel shock, but it is a margin-defence move, not a growth engine.
- cancelOperating leverage cuts both ways. Airlines carry high fixed costs, unionised labour with contractual escalators, and heavy capex. The same leverage that produced a $1.4bn pre-tax quarter turns a modest revenue miss into a disproportionate earnings miss.
- cancelSector-level tail risk is unhedgeable at the company level: pandemics, air-traffic-control disruption, a major safety event, or an escalation that closes airspace. These are low-probability, high-severity, and no amount of loyalty revenue offsets a grounded fleet.
#8SHW— Sherwin-Williams Company (The)
$317,44Forte acquistoFallen angel🇺🇸 USClenow 0,0W: Markdown14% dal highEARN: 2026-10-27 (46d)
The Sherwin-Williams Company is the largest paint and coatings manufacturer in the United States, founded in 1866 and headquartered in Cleveland, Ohio. It sells through three segments: Paint Stores Group, by far the biggest, which distributes architectural paint directly to professional painters, contractors and builders through a proprietary network of roughly 4,700-5,000 company-operated stores across North America — a captive distribution channel no competitor can easily replicate; Consumer Brands Group, which sells retail and DIY brands (Valspar, Minwax, Thompson's WaterSeal, Krylon, HGTV Home, Purdy) through third-party retailers such as Lowe's and Ace; and Performance Coatings Group, which supplies industrial and specialty coatings for automotive refinish, packaging, coil, wood and protective/marine applications worldwide. Annual revenue runs around $23-24 billion. The business is structurally a repaint and maintenance franchise — the majority of architectural paint volume comes from repainting existing buildings rather than new construction — which gives it more recurring demand than housing-start headlines imply. Sherwin-Williams is a dividend aristocrat with more than four decades of consecutive annual dividend increases, and joined the Dow Jones Industrial Average in November 2024.
P/E: 29,6 (fwd: 23,3)Rev Growth: +8%Margini: 11,0%ROE: 65,1%PEG: 2,89
Scenari di rimbalzoCorrezionetestato storicamenteEntry $317,44
Best SharpeConsigliato
Obiettivo$375,21
Tempo max150g
Tasso successo77%
Rendimento medio+7,9%
Max CAGRAggressivo
Obiettivo$422,48
Tempo max150g
Tasso successo82%
Rendimento medio+11,3%
Min MaxDDConservativo
Obiettivo$380,47
Tempo max120g
Tasso successo72%
Rendimento medio+6,3%
Hold-to-target — nessuno stop loss (nei backtest lo stop riduce i profitti su tutte le categorie). Tasso di successo e rendimento medio sono medie storiche di categoria, non valori del singolo titolo.
The defining tension in 2026 is that Sherwin-Williams is delivering company-specific execution into an end market that has not recovered. Residential new construction remains weak and DIY demand stays muted, yet Q2 2026 (reported 28 July) beat clearly: net sales $6.79 billion, up 7.5% and above the ~$6.61 billion consensus, adjusted EPS $3.70 versus ~$3.50 expected, and GAAP diluted EPS up 14.3% to $3.43, with growth in all three segments driven by new account wins, pricing discipline and cost control rather than by volume recovery. Management raised full-year 2026 guidance to mid-to-high single-digit sales growth and adjusted EPS of $11.80-$12.20 (consensus around $12.08, roughly +5.7% year over year), and the stock jumped ~8% on the print. The other live item is pricing power: the company pushed through an 8% price increase in the Paint Stores Group effective 1 September 2026, explicitly to offset high-single-digit raw-material inflation plus higher energy, logistics and packaging costs — and it did so while stating it does not expect a broad-based demand recovery, i.e. the earnings bridge for the next few quarters is price and mix, not units. The portfolio also now includes Suvinil, the Brazilian architectural paint business acquired from BASF and closed on 1 October 2025, which adds Latin American exposure and has been contributing to reported growth. Valuation is the pushback: at roughly $333 (early September 2026) the shares trade near 32x trailing and around 27-28x forward earnings, a premium to the chemicals sector (~28x) and to the peer group (~31x), with an average sell-side price target near $386 (~16% implied upside). The shares have underperformed over the past year on soft end-market demand and declining volumes, so the market is paying a quality multiple for a franchise whose unit demand is still shrinking.
thumb_upA favore
- check_circleQ2 2026 (28 July) beat on both lines in a bad end market: net sales $6.79 billion, +7.5% and above the ~$6.61 billion consensus, adjusted EPS $3.70 versus ~$3.50 expected, and GAAP diluted EPS +14.3% to $3.43 — with growth in all three segments coming from new account wins, pricing discipline and operational execution rather than from a demand rebound.
- check_circleManagement raised full-year 2026 guidance after the first half: consolidated sales now expected to grow a mid-to-high single-digit percentage and adjusted EPS guided to $11.80-$12.20. Guidance raises into a weak housing backdrop are the clearest evidence that the growth is self-generated.
- check_circleDemonstrated pricing power: an 8% price increase in the Paint Stores Group effective 1 September 2026, put through explicitly to recover high-single-digit raw-material inflation plus energy, logistics and packaging costs. Very few building-products suppliers can raise price high single digits into soft volumes without losing the customer.
- check_circleStructural moat in distribution: roughly 4,700-5,000 company-operated stores serving professional painters and contractors directly. The channel is captive, the pro customer is sticky and service-driven rather than price-shopping, and the majority of architectural volume is repaint/maintenance — more recurring than housing starts suggest.
- check_circlePortfolio expansion with Suvinil, the Brazilian architectural paint business bought from BASF and closed 1 October 2025, adding Latin American scale; plus a dividend-aristocrat record of more than four decades of consecutive increases and an average sell-side price target near $386 versus ~$333 (about 16% implied upside).
thumb_downContro
- cancelThe end market is still contracting: residential new construction is weak, DIY demand is muted, industry forecasts point to only slight paint-market growth for the rest of 2026, and management itself says it does not expect a broad-based demand recovery. Volumes have been declining — revenue growth is price and mix, not units.
- cancelValuation leaves no cushion: roughly 32x trailing and about 27-28x forward earnings at ~$333, a premium to the chemicals sector (~28x) and to the peer group (~31x), for a company guided to only ~6% adjusted EPS growth in 2026. Any quarter that misses the pricing-led bridge de-rates a premium multiple fast.
- cancelThe 8% September price increase is a two-sided lever: it defends gross margin against high-single-digit raw-material inflation, but it also hands share to competitors (PPG, Behr/Masco at Home Depot, Benjamin Moore) if pro customers trade down. Price-led growth with falling volumes is inherently self-limiting — elasticity shows up with a lag, in Q4 and 2027, not immediately.
Bear case · Sherwin-Williams can keep compounding earnings through the housing downturn because pricing, new account wins and cost control substitute for volume, as they did in Q2 2026. → That bridge is arithmetically finite. Volumes have been falling, the company explicitly guides to no broad-based demand recovery, and the 8% September increase is itself a defensive response to high-single-digit raw-material inflation — i.e. the price is being used to hold margin, not to expand it. If elasticity bites and pro customers trade down to PPG or Behr, the company loses units AND the price carry at the same time, and the 'execution beats the market' narrative that drove the ~8% post-earnings rally unwinds.
Bear case · The premium multiple is justified by the quality of the franchise: the captive store network, the repaint/maintenance mix and the dividend-aristocrat record deserve to trade above chemicals peers. → The market is paying roughly 27-28x forward for guided adjusted EPS growth of about 5.7% — a PEG well above 4 — while the stock has already underperformed over the past year on softening demand and declining volumes. Quality does not protect against a de-rating when the growth rate no longer supports the multiple; a single guidance cut, a mortgage-rate environment that keeps existing-home turnover frozen, or a raw-material spike the price increase fails to cover would compress the multiple toward the ~28x sector average before earnings even fall.
eventTrimestrale 2026-10-27 (tra 46g) · Q3 2026 results expected around 27 October 2026. Focus on: (1) early read-through on the 8% Paint Stores Group price increase effective 1 September — realised price capture versus volume/share loss to PPG and Behr; (2) whether volumes are still declining or finally stabilising in Paint Stores Group, given no expected broad-based demand recovery; (3) gross margin versus high-single-digit raw-material, energy and logistics inflation; (4) confirmation or narrowing of the raised full-year adjusted EPS range of $11.80-$12.20 and mid-to-high single-digit sales growth; (5) Suvinil contribution and the Latin America/industrial (Performance Coatings) trajectory.candlestick_chartTradingView #9PSA— Public Storage
$294,60Forte acquistoFallen angel🇺🇸 USClenow 12,5W: Markdown11% dal highEARN: 2026-10-28 (55d)
Public Storage is the largest self-storage REIT in the world and a member of the S&P 500, listed on the NYSE. Its business is renting small storage units month-to-month to households and small businesses: leases are effectively 30-day contracts, so the landlord can reprice the whole portfolio within a year, but demand is tied to life events (moving, marriage, divorce, death, downsizing) and therefore to housing turnover. Following the July 2026 all-stock acquisition of National Storage Affiliates, the portfolio spans more than 4,500 locations and roughly 327 million rentable square feet across the United States, plus a stake in the European operator Shurgard and a pending purchase of Public Storage Canada. The economics are unusual for real estate: operating margins above 40%, very low maintenance capex per square foot, and heavy use of digital/self-service leasing, which is why the company earns a mid-20s return on equity despite very slow revenue growth. Structurally it is a scale consolidator in a fragmented industry where roughly three quarters of US capacity is still owned by small independent operators. Founded in 1972 and headquartered in Glendale, California, it converted to REIT status and distributes most of its taxable income as dividends.
P/E: 28,1 (fwd: 29,1)Rev Growth: +3%Margini: 41,6%ROE: 21,9%PEG: 1,95
Scenari di rimbalzoCorrezionetestato storicamenteEntry $294,60
Best SharpeConsigliato
Obiettivo$334,06
Tempo max150g
Tasso successo77%
Rendimento medio+7,9%
Max CAGRAggressivo
Obiettivo$366,34
Tempo max150g
Tasso successo82%
Rendimento medio+11,3%
Min MaxDDConservativo
Obiettivo$337,64
Tempo max120g
Tasso successo72%
Rendimento medio+6,3%
Hold-to-target — nessuno stop loss (nei backtest lo stop riduce i profitti su tutte le categorie). Tasso di successo e rendimento medio sono medie storiche di categoria, non valori del singolo titolo.
The dominant story is a merger completed into a still-soft operating cycle. On 22 July 2026 Public Storage closed the all-stock acquisition of National Storage Affiliates (enterprise value about $10.5 billion, 0.14 PSA shares per NSA share), adding more than 1,000 properties and 69 million square feet across 37 states; management guides the deal to add $0.35-$0.50 to Core FFO per share at stabilization. Part of the NSA assets was carved into a joint venture of 313 properties (about $3.3 billion, 80% owned by legacy NSA partners and 20% by PSA, roughly 70% leverage, $2.2 billion of property-level secured debt plus a ~$240 million mezzanine loan from PSA). A separate $1.2 billion purchase of Public Storage Canada was announced for Q3 2026 close. Meanwhile the core portfolio is still shrinking on a like-for-like basis: Q2 2026 same-store revenue fell 0.6% and same-store NOI fell 2.2% year-over-year, and Core FFO per share of $4.17 was down 2.6%, although both beat the company's own forecast. The genuine inflection signal is pricing: average move-in rents turned positive at +1.6% after a long stretch of negative new-customer rates, with same-store occupancy at 92.5% (+0.2pp). Management raised full-year 2026 Core FFO guidance to $16.75-$17.05 per share (+$0.22 at the midpoint) on better same-store trends, lower interest expense and non-same-store contribution. The macro brake is unchanged: US existing-home sales around 4.35 million annualized are roughly 16% below long-run averages, and housing turnover is the primary demand funnel for storage; sector supply growth is finally moderating, which is what a recovery would need. Sentiment is poor - BofA cut storage REITs including PSA citing the absence of near-term operational catalysts and Los Angeles wildfire-related pricing restrictions - and the stock trades around $301, about 9% below its 20-day high and roughly 9% below the 52-week high of $330, with RSI near 17 (deeply oversold) and a weak Clenow trend score. Note on valuation: the headline forward P/E near 30x is computed on GAAP EPS, which for a REIT is depressed by depreciation; on the guided Core FFO midpoint the multiple is closer to 18x, with a dividend of $3.00 per quarter (~4% yield, roughly 71% of Core FFO).
thumb_upA favore
- check_circlePricing inflection actually visible in the tape, not just narrated: Q2 2026 average move-in rents turned positive at +1.6% after a prolonged run of negative new-customer rates, with same-store occupancy at 92.5% (+0.2pp YoY). Because self-storage leases are month-to-month, a sustained recovery in move-in rates feeds the whole rent roll within roughly a year - this is the single metric that historically leads the cycle turn.
- check_circleGuidance raised into a soft quarter: full-year 2026 Core FFO per share lifted to $16.75-$17.05 (+$0.22 at the midpoint) on better same-store performance, lower interest expense and non-same-store/ancillary contribution. Same-store revenue (-0.6%) and NOI (-2.2%) declined but beat the company's own internal forecast.
- check_circleThe NSA merger closed on 22 July 2026 (all-stock, ~$10.5bn enterprise value, 0.14 PSA per NSA share), adding 1,000+ properties and 69m sq ft across 37 states and taking the platform to 4,500+ locations and ~327m sq ft. Management guides $0.35-$0.50 of Core FFO per share accretion at stabilization - a scale/consolidation lever that does not require the operating cycle to turn. A $1.2bn Public Storage Canada acquisition is set to close in Q3 2026.
- check_circleExceptional unit economics for real estate: 41.6% profit margins, 21.9% ROE and a 4.1% FCF yield, with very low maintenance capex per square foot and digital self-service leasing. Dividend of $3.00 per quarter is roughly 71% of guided Core FFO - covered, not stretched.
- check_circleValuation is far cheaper than the screen suggests: the 29.9x forward P/E is computed on GAAP EPS, which for a REIT is artificially depressed by depreciation. On the guided Core FFO midpoint the multiple is about 18x, near the low end of the post-2021 range for the sector leader. Entry technicals are washed out: RSI 16.6, ~-8.8% from the 20-day high.
- check_circleSector supply growth is moderating after the post-pandemic construction surge - the necessary (if not sufficient) condition for pricing power to return in the oversupplied Sun Belt markets.
thumb_downContro
- cancelThe core portfolio is still contracting on a like-for-like basis: same-store revenue -0.6% and same-store NOI -2.2% YoY, with Core FFO per share of $4.17 down 2.6% YoY. Beating one's own lowered forecast is not the same as growth; total revenue also came in well below street expectations.
- cancelThe demand funnel is broken at the macro level and PSA cannot fix it: US existing-home sales around 4.35m annualized sit roughly 16% below long-run averages and ~20% below pre-pandemic levels. Housing turnover (moves, downsizing, life events) is the primary source of new storage customers - without mortgage-rate relief and transaction volume, move-in demand stays structurally thin.
- cancelBalance-sheet and structure complexity increased: the NSA carve-out joint venture (313 properties, ~$3.3bn) runs at roughly 70% leverage with $2.2bn of property-level secured debt and PSA holding only 20% equity plus a ~$240m mezzanine loan. Consolidated debt/equity is already 109.6% and the current ratio is 0.22; the scanner's own defensive screen fails PSA on liquidity.
- cancelSell-side and momentum are against the name: BofA cut storage REITs including PSA on the absence of near-term operational catalysts and Los Angeles wildfire-related pricing restrictions. Clenow trend strength is 12.5 (very weak) and the Wyckoff read is Markdown - this is a value/mean-reversion setup, not a trend entry.
- cancelRate sensitivity cuts both ways. As a low-growth, ~4%-yielding REIT, PSA competes directly with T-bills and long Treasuries; in a RATE_HIKE or sticky-inflation regime the multiple compresses regardless of operating execution, and 3.3% revenue growth offers no offset.
Bear case · Move-in rents turning +1.6% marks the cycle bottom, so same-store revenue reaccelerates through 2027 and the ~18x Core FFO multiple re-rates. → Move-in rates are being lapped against very easy 2025 comparisons; sector commentary explicitly flags that firmer move-in pricing may reflect base effects rather than a material improvement in underlying demand. Same-store NOI is still -2.2% and existing-home sales - the actual customer funnel - are ~16% below long-run averages with no rate catalyst dated. A +1.6% move-in rate on 92.5% occupancy is not enough to turn revenue positive if in-place customers keep churning at flat-to-negative renewals, and one quarter of positive prints has repeatedly failed to persist in this cycle.
Bear case · The NSA merger adds $0.35-$0.50 to Core FFO per share at stabilization, so scale accretion carries earnings even if the operating cycle stays soft. → That figure is management's own estimate 'at stabilization' with no stated date, and it assumes PSA can lift NSA's rents and occupancy onto its own platform - into the same weak demand environment that is currently pushing PSA's own same-store NOI down 2.2%. It is an all-stock deal, so the share count rose immediately while the accretion arrives later: per-share dilution is booked now, the benefit is a forecast. The 313-property joint venture is 70%-levered, majority-owned by legacy NSA partners and only 20% PSA equity - PSA absorbed integration complexity and a ~$240m mezzanine exposure while keeping a minority economic interest in those assets.
Bear case · The 4% dividend yield plus 41% margins and 22% ROE make this a defensive holding while waiting for the turn. → The scanner's own defensive filter rejects PSA (current ratio 0.22), debt/equity is 109.6%, and the dividend has been frozen at $3.00 per quarter since 2022 - a low-growth yield, not a growing one. As a bond-proxy REIT, PSA's drawdown risk is dominated by the long end of the curve, not by its operations: in a sticky-inflation or hawkish-Fed regime it can fall alongside equities while offering none of the upside convexity, which is exactly the shape of the -8.8% dip currently on screen.
eventTrimestrale 2026-10-28 (tra 55g) · Q3 2026 results expected in late October 2026 (date not yet confirmed by the company). Watch: (1) whether the +1.6% move-in rate improvement persists or fades once the easy 2025 comparisons lapse - this is the single number that decides the bull thesis; (2) same-store revenue and NOI, which need to move from -0.6%/-2.2% toward flat for the cycle-bottom call to hold; (3) the first quarter of consolidated NSA contribution, with any restated timeline for the $0.35-$0.50 per-share accretion and integration costs; (4) the close and initial terms of the $1.2bn Public Storage Canada acquisition; (5) any further move in full-year Core FFO guidance from the raised $16.75-$17.05 range, and interest expense after the added property-level debt.candlestick_chartTradingView #10RTX— RTX Corporation
$198,12Forte acquistoFallen angel🇺🇸 USClenow 12,6W: Markdown12% dal high
RTX Corporation is one of the world's largest aerospace and defense groups, born from the 2020 merger of Raytheon and United Technologies' aerospace businesses. It runs on three legs. Collins Aerospace supplies the 'nervous system and body parts' of aircraft: avionics, landing gear, interiors, power systems. Pratt & Whitney designs and builds jet engines, including the geared turbofan (GTF) that powers much of the Airbus A320neo family, plus the F135 engine for the F-35 fighter. Raytheon is the defense arm: air and missile defense (Patriot, the NASAMS system, SPY-6 naval radars), effectors and missiles. The business model is the classic 'razor and blades' of aerospace: original equipment is sold at thin or even negative margins, and the money is made afterwards over decades of aftermarket — spare parts, maintenance, overhauls — on an installed base that keeps flying for 25-30 years. That aftermarket stream is the reason the commercial half is far more profitable than the headline engine sale suggests. On the defense side, revenue is driven by government budgets and multi-year programs, which makes it slow to accelerate but also slow to disappear: backlog converts into sales over many years. Barriers to entry are extreme — certification, installed base, security clearances, and the sheer capital required — which is why the industry is a handful of players rather than a competitive marketplace.
P/E: 34,7 (fwd: 25,2)Rev Growth: +14%Margini: 8,3%ROE: 12,3%PEG: 3,12
Scenari di rimbalzoCorrezionetestato storicamenteEntry $198,12
Best SharpeConsigliato
Obiettivo$228,23
Tempo max150g
Tasso successo77%
Rendimento medio+7,9%
Max CAGRAggressivo
Obiettivo$252,86
Tempo max150g
Tasso successo82%
Rendimento medio+11,3%
Min MaxDDConservativo
Obiettivo$230,96
Tempo max120g
Tasso successo72%
Rendimento medio+6,3%
Hold-to-target — nessuno stop loss (nei backtest lo stop riduce i profitti su tutte le categorie). Tasso di successo e rendimento medio sono medie storiche di categoria, non valori del singolo titolo.
RTX is in a strong operating phase. Q2 2026 (reported 23 July) showed $24.7bn of sales, up ~14.5% year on year with 16% organic growth, adjusted EPS of $1.89, and segment margins expanding about 40 basis points. Backlog hit a record $289bn — $170bn commercial, $119bn defense — up 22% year on year, with Raytheon alone booking nearly $20bn in the quarter (book-to-bill around 2.4) and international now roughly 48% of its backlog, reflecting European and Middle East rearmament demand for air-defense systems. Management raised full-year 2026 guidance across the board: sales to $95-96bn, adjusted EPS to $7.10-7.25 (from $6.70-6.90) and free cash flow to $8.5-8.75bn. The stock trades near $200, with sell-side price targets clustering around $227-235. The unresolved overhangs are the Pratt & Whitney GTF powder-metal defect, which continues to drive accelerated inspections, elevated aircraft-on-ground counts and customer-compensation costs, and tariffs, which cost roughly $500m in absorbed IEEPA costs and hit Collins and Pratt margins by 130 and 50 basis points respectively in Q1 2026. Supply-chain throughput on rocket motors, castings and microelectronics remains the practical ceiling on how fast the record backlog can be converted into revenue.
thumb_upA favore
- check_circleRecord $289bn backlog (+22% y/y), split $170bn commercial and $119bn defense — multi-year revenue visibility that few industrials can match.
- check_circleGuidance raised across every metric at Q2 2026: sales to $95-96bn, adjusted EPS to $7.10-7.25 from $6.70-6.90, free cash flow to $8.5-8.75bn.
- check_circleRaytheon book-to-bill of roughly 2.4 in Q2 with international at ~48% of segment backlog — European and Middle East air-defense rearmament is a demand source largely independent of the US budget cycle.
- check_circleAftermarket economics: the installed base of GTF and legacy engines plus Collins content generates decades of high-margin spares and overhaul revenue after the original equipment sale.
- check_circleOperating leverage is showing up in the numbers, not just the order book: 16% organic growth with segment margins up ~40bp in Q2 2026.
thumb_downContro
- cancelThe GTF powder-metal defect is still not closed: accelerated inspections, elevated aircraft-on-ground levels and customer compensation keep weighing on Pratt's margins and cash.
- cancelTariff exposure is material — roughly $500m of absorbed IEEPA costs, with a 130bp margin headwind at Collins and 50bp at Pratt in Q1 2026 — and depends on trade policy RTX does not control.
- cancelSupply-chain throughput (rocket motors, castings, microelectronics) is the practical bottleneck: backlog only becomes revenue as fast as the supply base can scale.
- cancelAfter a strong run the stock is no longer cheap on earnings multiples; the valuation case now rests on cash flow rather than on a discount.
- cancelDefense revenue depends on government budgets and appropriations timing, which can slip regardless of how strong the order book looks.
#11ACA.PA— CREDIT AGRICOLE
€18,44AcquistoSwing momentum🇫🇷 FRClenow 12,5W: Accumulazione9% dal highDATA GAP
Crédit Agricole S.A. (ACA.PA) is the listed entity of the Crédit Agricole Group, one of the largest banking groups in Europe and the leading retail bank in France. Its structure is unusual: the listed company is majority-owned by SAS Rue La Boétie, the holding vehicle of the 39 regional cooperative banks (Caisses Régionales), which pool their business lines inside the listed vehicle. Revenue comes from four main engines: French and international retail banking (LCL in France, Crédit Agricole Italia and other European units); the large-customer division (corporate and investment banking, capital markets, asset servicing via CACEIS); asset gathering, which includes Amundi, Europe's largest asset manager, plus insurance (Crédit Agricole Assurances, the group's most profitable business) and wealth management; and specialised financial services (consumer credit through CA Consumer Finance/Agos, leasing and factoring). Roughly speaking, the bank earns money in three ways: the interest spread between what it pays depositors and what it charges borrowers (net interest income), fees on assets it manages or administers, and insurance premiums and technical margins. The heavy weight of insurance and asset management makes its earnings less rate-sensitive and less cyclical than those of a pure lender, while the cooperative ownership structure means control is not contestable — no hostile takeover of the listed entity is realistically possible.
P/E: 9,3 (fwd: 7,5)Rev Growth: −6%Margini: 25,3%ROE: 8,6%
Scenari di rimbalzoDiptestato storicamenteEntry €18,44
Best SharpeConsigliato
Obiettivo€20,73
Tempo max240g
Tasso successo85%
Rendimento medio+6,2%
Max CAGRAggressivo
Obiettivo€21,96
Tempo max120g
Tasso successo73%
Rendimento medio+8,5%
Min MaxDDConservativo
Obiettivo€20,38
Tempo max120g
Tasso successo75%
Rendimento medio+4,7%
Hold-to-target — nessuno stop loss (nei backtest lo stop riduce i profitti su tutte le categorie). Tasso di successo e rendimento medio sono medie storiche di categoria, non valori del singolo titolo.
Crédit Agricole S.A. is the listed vehicle of the French mutual banking group, combining retail networks, asset management, insurance and corporate banking. It trades at 9.3x trailing and 7.5x forward earnings with 25% net margins, and sits -8.7% below its 52-week high of €20.20 with RSI at 21.1. Wyckoff flags Accumulation A with a Selling Climax, but at score 1 and weak strength. The fundamental picture is the weakest of the five picks: revenue -6.3% year over year, Q1 2026 net income -7.9% with EPS at €0.52 against €0.56, ROE 8.6% failing the defensive filter and earnings quality at -1.29x. The offsetting evidence is commercial: 600,000 new retail customers in Q1 2026 and a sharp rise in regional-bank net interest income.
thumb_upA favore
- check_circleWyckoff Accumulation A (Selling Climax) with RSI at 21.1: a capitulation reading on a -8.7% drawdown from the 52-week high
- check_circle7.5x forward earnings with 25% net margins: cheapest multiple in the basket alongside BNP.PA
- check_circleCommercial franchise still expanding: 600,000 new retail customers in Q1 2026 and a sharp year-over-year rise in regional-bank net interest income
- check_circleThe French-bank selloff has already been framed by sell-side as an overreaction to political risk (Jefferies upgrade to Buy)
thumb_downContro
- cancelFundamentals deteriorating at the margin: revenue -6.3% year over year and Q1 2026 net income -7.9%, with EPS down to €0.52 from €0.56
- cancelEarnings quality -1.29x means reported profit is not backed by cash flow; the metric is noisy for a bank, but it is still the weakest reading in the basket
- cancelFails the defensive filter on ROE 8.6% and shows Clenow at 12.5: no momentum support and the weakest Wyckoff score of the five
Bear case · The revenue contraction is a comparison effect that reverses inside the swing window → Revenue -6.3% and net income -7.9% year over year come with declining EPS: this is the one pick where the drop may be fundamental rather than macro-driven, and the Wyckoff guide treats a weak pattern plus deteriorating fundamentals as a skip
Bear case · A cheap French bank with a Selling Climax is an asymmetric setup → It shares its driver with BNP.PA in this same basket, so a French sovereign or political shock hits both positions at once: held together they are one bet sized twice, not two independent ones
Bear case · The Selling Climax marks the low → Wyckoff score is 1 with weak strength and no Secondary Test; the checklist requires an SC on volume above 1.5x average plus a support test that holds before the pattern counts as confirmed
#12BNP.PA— BNP PARIBAS ACT.A
€102,56Forte acquistoSwing momentum🇫🇷 FRClenow 50,5W: Accumulazione9% dal highEARN: 2026-10-28 (57d)DATA GAP
BNP Paribas SA is the largest bank in the euro area by assets, headquartered in Paris and listed on Euronext Paris. It is a universal bank — meaning it combines retail banking for households and small businesses with corporate lending, capital markets and asset management under one roof — organised around three divisions: Corporate & Institutional Banking (CIB: financing, advisory, and Global Markets trading in equities, rates, FX and credit), Commercial, Personal Banking & Services (the domestic retail networks in France, Italy via BNL, Belgium and Luxembourg, plus specialised businesses such as Arval vehicle leasing, BNP Paribas Personal Finance consumer credit and leasing solutions), and Investment & Protection Services (asset management, wealth management and insurance through BNP Paribas Cardif). Founded in its current form in 2000 through the merger of BNP and Paribas, the group operates in around 60 countries with roughly 180,000 employees and generates annual net banking income in the order of €50 billion. As a euro-area systemically important bank it is supervised directly by the ECB, and its earnings are structurally sensitive to euro-area interest rates, French and Italian credit conditions, and capital-markets activity levels.
P/E: 8,9 (fwd: 7,8)Rev Growth: +19%Margini: 26,5%ROE: 10,5%
Scenari di rimbalzoDiptestato storicamenteEntry €102,56
Best SharpeConsigliato
Obiettivo€115,87
Tempo max240g
Tasso successo85%
Rendimento medio+6,2%
Max CAGRAggressivo
Obiettivo€123,04
Tempo max120g
Tasso successo73%
Rendimento medio+8,5%
Min MaxDDConservativo
Obiettivo€113,82
Tempo max120g
Tasso successo75%
Rendimento medio+4,7%
Hold-to-target — nessuno stop loss (nei backtest lo stop riduce i profitti su tutte le categorie). Tasso di successo e rendimento medio sono medie storiche di categoria, non valori del singolo titolo.
BNP Paribas is the largest euro-area bank by assets, diversified across corporate and institutional banking, retail networks in France, Italy and Belgium, insurance and asset management. It trades at 8.9x trailing and 7.8x forward earnings with 26% net margins, +18.8% revenue growth, earnings quality 2.14x and a 38.8% FCF yield. The stock is -9.1% below its 20-day high. Wyckoff flags Accumulation A with a Selling Climax, the only qualifying dip in the scan carrying an accumulation phase, but with score 1 and weak strength, meaning the capitulation has not yet been confirmed by a Secondary Test on lower volume. On a -9% dip the Wyckoff overlay is worth roughly +0.8% versus buying immediately, so valuation and capital return carry the thesis while the pattern acts as the tie-breaker.
thumb_upA favore
- check_circleCheapest valuation in the swing basket: 7.8x forward earnings with 26% net margins and +18.8% revenue growth
- check_circleOnly qualifying dip in the scan showing a Wyckoff Accumulation A (Selling Climax) phase
- check_circleCapital return is contractual rather than hoped for: €1.15B buyback authorized by the ECB running to 2026-11-13, with the CET1 target raised to 13% by 2027
- check_circleEarnings quality 2.14x and FCF yield 38.8%: reported profit is backed by cash
- check_circleSell-side consensus is one-sided (14 buy ratings, no sell) with a cost/income target of 61% in 2026
thumb_downContro
- cancelWyckoff score 1 and weak strength: the Selling Climax has no Secondary Test confirmation, so the pattern can still fail
- cancelOn a -9% dip the measured Wyckoff edge is only about +0.8%, so most of the thesis rests on valuation rather than on the pattern
- cancelROE 10.5% is mediocre and the data gap on current ratio and debt/equity makes the defensive check less conclusive
Bear case · The -9.1% is a technical dip on a bank with intact fundamentals → Crédit Agricole appears in the same scan on the same move: this is a French banking sector drawdown, so a sovereign-spread or political shock would hit both picks together rather than idiosyncratically
Bear case · The buyback puts a floor under the price through the holding period → The €1.15B program expires on 2026-11-13, inside the 40-150 day swing window, and renewal depends on the year-end decision about excess capital above the 13% CET1 threshold
Bear case · A 7.8x forward multiple is by itself a margin of safety → Euro-area banks re-rate with the rate cycle; an ECB easing path compresses net interest income and a cheap multiple can stay cheap for several quarters
loginEntry €102,56eventTrimestrale 2026-10-28 (tra 57g) · insufficient data — no EPS consensus in sources (Q3 2026 results)candlestick_chartTradingView #13BA— Boeing Company (The)
$209,82Forte acquistoSwing momentum🇺🇸 USClenow 0,1W: Struttura rotta17% dal highDATA GAP
The Boeing Company (NYSE: BA) is one of the two global duopolists in large commercial aircraft, alongside Airbus, and simultaneously one of the largest US defence and space contractors. Founded in 1916 and headquartered in Arlington, Virginia, it operates through three main segments: Boeing Commercial Airplanes (BCA), which designs and builds the 737 MAX, 787 Dreamliner, 767, 777 and the forthcoming 777X families; Boeing Defense, Space & Security (BDS), which covers fighters (F-15EX, F/A-18), rotorcraft (Apache, Chinook), tankers (KC-46), satellites, missiles and the VC-25B presidential aircraft programme; and Boeing Global Services (BGS), the aftermarket arm selling spare parts, maintenance, modifications and training on the installed fleet. The economics of the business are those of a long-cycle industrial: aircraft are sold years before they are built, so revenue is governed by a multi-year order backlog and cash generation depends almost entirely on the physical delivery rate — how many aircraft actually roll out of the factory per month. BGS is the structurally high-margin, recurring-revenue segment, while BCA is the cash swing factor. Barriers to entry are extreme (certification, capital intensity, installed base), which is why the duopoly persists despite years of operational difficulty.
P/E: 75,0 (fwd: 50,4)Rev Growth: +8%Margini: 2,6%ROE: 173,5%
Scenari di rimbalzoFallentestato storicamenteEntry $209,82
Best SharpeConsigliato
Obiettivo$294,48
Tempo max180g
Tasso successo80%
Rendimento medio+18,9%
Max CAGRAggressivo
Obiettivo$294,48
Tempo max180g
Tasso successo80%
Rendimento medio+18,9%
Min MaxDDConservativo
Obiettivo$273,31
Tempo max150g
Tasso successo79%
Rendimento medio+16,4%
Hold-to-target — nessuno stop loss (nei backtest lo stop riduce i profitti su tutte le categorie). Tasso di successo e rendimento medio sono medie storiche di categoria, non valori del singolo titolo.
Boeing builds commercial aircraft (737, 787, 777X), defense systems and space hardware, and is midway through a production recovery after years of quality and certification setbacks. The stock is -16.8% off its 52-week high of $252.15 with RSI at 11.5, the most extreme oversold reading in this scan. The operational data is improving: 171 deliveries in Q2 2026, up 14% year over year and the best quarter since 2018, the 737 line moving toward 47 aircraft per month, FAA certification of the MAX 7 in August 2026, a record $597B commercial backlog and free cash flow guided up to roughly $3B. The balance sheet has not recovered with it: D/E is 790.9% on 2.6% net margins and 50.4x forward earnings, so the whole thesis rests on the ramp continuing uninterrupted. Wyckoff: Markdown, moderate strength.
thumb_upA favore
- check_circleRSI 11.5 is the most extreme oversold reading in the whole scan, on a -16.8% drawdown
- check_circleModerate Wyckoff strength in the -15% bucket, ranking factor number one in our backtests (+2.7% versus buy-immediately)
- check_circleOperational turnaround is documented, not narrative: 171 deliveries in Q2 (+14% y/y, best since 2018), 737 rate moving to 47 per month, FAA certified the MAX 7 in August 2026
- check_circleRecord $597B commercial backlog plus a large defense award, with free cash flow guided up to about $3B this year
- check_circleEarnings quality 1.74x and FCF yield 3.4%: cash generation is running ahead of accounting profit
thumb_downContro
- cancelD/E 790.9% is by far the worst balance sheet in the scan; the defensive filter fails and there is no cushion for a new operational shock
- cancelForward P/E 50.4x on 2.6% net margins: you pay for a recovery that has not landed in the income statement yet
- cancelAn authorized engineers' strike could halt the production ramp on which the entire thesis depends
Bear case · The delivery ramp converts into cash and starts de-levering the balance sheet → An authorized strike by engineers can freeze the ramp; with D/E at 791% and 2.6% net margins, a delivery pause goes straight through to liquidity
Bear case · RSI 11.5 marks capitulation and therefore a bottom → Wyckoff still reads Markdown with no Higher Low and Clenow at 0.1; the measured edge in our backtests sits on the pattern, not on the oscillator, so oversold alone is not an entry signal
Bear case · Certification milestones are catalysts not yet priced in → MAX 7 certification already landed in August 2026 and the stock is still -17% from its high, which is direct evidence the tape absorbed it without re-rating
#14HD— Home Depot, Inc. (The)
$330,19Forte acquistoSwing momentum🇺🇸 USClenow 0,0W: Struttura rotta20% dal highEARN: 2026-11-17 (77d)
The Home Depot is the world's largest home-improvement retailer: roughly 2,300+ big-box stores across the US, Canada and Mexico selling building materials, lumber, appliances, tools, garden and decor products. Revenue splits between DIY consumers (homeowners doing their own projects) and the 'Pro' channel (contractors, builders, maintenance crews), the latter being the higher-ticket, higher-frequency and strategically prioritised segment. The business model is scale-driven: enormous purchasing power over suppliers, dense store network doubling as a distribution grid for same-day delivery, and a supply chain built around large-order 'complex Pro' jobs, reinforced by the acquisitions of SRS Distribution (roofing/pool/landscaping distribution) and GMS (drywall and building products). Economically, HD is a leveraged bet on the US housing cycle: revenue depends on home turnover, home equity values, mortgage rates and renovation appetite, not on new-build volumes alone. Structurally it is a low-margin-per-item, high-turnover retailer with best-in-class returns on capital, a long history of dividend growth and buybacks, and a duopoly position versus Lowe's.
P/E: 22,9 (fwd: 20,4)Rev Growth: +6%Margini: 8,4%ROE: 104,3%
Scenari di rimbalzoFallentestato storicamenteEntry $330,19
Best SharpeConsigliato
Obiettivo$499,40
Tempo max180g
Tasso successo80%
Rendimento medio+18,9%
Max CAGRAggressivo
Obiettivo$499,40
Tempo max180g
Tasso successo80%
Rendimento medio+18,9%
Min MaxDDConservativo
Obiettivo$457,10
Tempo max150g
Tasso successo79%
Rendimento medio+16,4%
Hold-to-target — nessuno stop loss (nei backtest lo stop riduce i profitti su tutte le categorie). Tasso di successo e rendimento medio sono medie storiche di categoria, non valori del singolo titolo.
Home Depot is the largest US home-improvement retailer, with a professional-contractor channel that has become the growth engine and a distribution arm expanded through the SRS and GMS acquisitions. The stock is -20.4% off its 52-week high of $414.79 and roughly 25% below its 2024 peak, on a housing market that has moved from slowdown to crawl and on tariff-driven cost pressure. The business itself has not broken: Q2 revenue grew 5.7% with Pro demand and delivery improving, earnings quality is 1.32x and ROIC 21%. What has broken is the multiple and the margin, with operating margin near a decade low and roughly $119M per quarter of SRS intangible amortization compressing reported figures. Wyckoff phase is Markdown with weak strength: the -20% bucket is where the overlay pays most, but here the pattern itself is thin.
thumb_upA favore
- check_circle-20.4% drawdown puts it in the bucket where the Wyckoff overlay is worth the most (+3.9% delta in backtest)
- check_circleThe business is still growing through the housing slowdown: Q2 revenue +5.7%, with Pro demand and delivery both improving
- check_circleCash generation intact: FCF yield 3.3%, earnings quality 1.32x (cash flow above accounting profit), ROIC 21%
- check_circleNo earnings inside the entry window: the next print is 2026-11-17, 77 days away
thumb_downContro
- cancelFails the defensive filter on D/E 380% with PEG 4.27: leverage is high and growth does not justify 20.4x forward earnings
- cancelThe driver is macro (housing at a crawl, tariff cost pressure) with no dated resolution, and operating margin is near a decade low
- cancelWyckoff strength only weak inside a Markdown phase, with Clenow at 0.0: zero trend support
Bear case · Housing weakness is cyclical and mean-reverts inside the 40-150 day window → Management has already guided first-half EPS negative year over year and the stock is 25% below its 2024 high: this is a multi-quarter trend, not the kind of shock a swing horizon is designed to capture
Bear case · Compressed margins are the result of transitory items → Roughly $119M per quarter of SRS intangible amortization plus tariff cost pressure persist for several quarters, and operating margin is already at a decade low
Bear case · D/E at 380% is normal for a lease-heavy retailer and not a real risk → Untested in our backtests; the defensive filter fails on it, and leverage amplifies any downgrade to consumer-spending expectations
loginEntry $330,19eventTrimestrale 2026-11-17 (tra 77g) · insufficient data — no EPS consensus in sources (Q3 FY2026)candlestick_chartTradingView